Physician profile
John W Mcclellan
NPI 1114920592
$3,535.80
in general payments reported to CMS, 2019-2025
11 companies · $869 in 2025
The $869 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $31.25 · 2022: $15.55 · 2023: $2,374 · 2024: $40.03 · 2025: $869.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,429 · Food and Beverage: $854.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,429.40 |
| Food and Beverage | $853.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,144.48 | 2023 | Proclaim, Infinity |
| Conetic Solutions, INC. | $635.25 | 2025 | |
| Medtronic, INC. | $229.37 | 2023 | Intellis Adaptivestim, Mazor X System |
| Arthrex, INC. | $209.95 | 2025 | |
| Aesculap Implant Systems, LLC | $123.57 | 2019 | |
| Cerapedics INC. | $64.04 | 2024-2025 | I-Factor Peptide Enhanced Bone Graft |
| Baxter Healthcare | $48.34 | 2019 | |
| Boston Scientific Corporation | $31.80 | 2019-2020 | |
| Orthofix Medical, INC. | $19.08 | 2019 | |
| Si-Bone, INC. | $15.55 | 2022 | |
| Misonix INC | $14.37 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcclellan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.